All In Biotech

Drug Trial Radar · NCT00889382

A Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

A Phase 1/2 Study Evaluating Intermittent and Continuous OSI-906 and Weekly Paclitaxel in Patients With Recurrent Epithelial Ovarian Cancer (and Other Solid Tumors)

Last checked: Nov 19, 2026Latest source record: Nov 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 152 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

152

Actual

Start

Aug 5, 2009

Primary completion

Aug 1, 2014

Study completion Aug 25, 2014

Sponsor

Lead sponsor
Astellas Pharma IncAstellas (ALPMY)
Sponsor type
Industry
First posted
Apr 28, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1 / Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a multi-center, randomized, open-label, phase 1/2 study of continuous weekly paclitaxel and escalating doses of intermittent or continuous OSI-906 in patients with recurrent/relapsed ovarian and other solid tumors.

Conditions

  • Ovarian Cancer
  • Solid Tumors

Interventions

  • OSI-906Drug

    Administered orally

  • PaclitaxelDrug

    Administered intravenously

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Determine Maximum Tolerated Dose (MTD) and Recommended Phase 2 Dose (RP2D)Time frame: 28 days
  2. Progression Free Survival (PFS)Time frame: 36 months

Locations

46 sites in 10 countries. Site status is shown where the registry gives one.

  • Mayo Clinic

    Scottsdale, Arizona

  • Department of Obstetrics and Gynecology, University of California, Irvine

    Orange, California

  • Horizon Oncology Center

    Lafayette, Indiana

  • Ochsner Clinic Foundation

    New Orleans, Louisiana

  • Morristown Memorial Hospital

    Morristown, New Jersey

  • Blumenthal Cancer Center - Main

    Charlotte, North Carolina

  • Duke University Medical Center

    Durham, North Carolina

  • University of Oklahoma Health Sciences Center

    Oklahoma City, Oklahoma

  • WestMead Hospital

    Westmead, New South Wales, Australia

  • Mater Adult Hospital

    South Brisbane, Queensland, Australia

  • Royal Adelaide Hospital

    North Terrace, South Australia, Australia

  • Launceston General Hospital

    Launceston, Tasmania, Australia

  • Frankston Hospital

    Frankston, Victoria, Australia

  • Border Medical Oncology

    Wodonga, Victoria, Australia

  • St. John of God Hospital, Bunbury

    Bunbury, Western Australia, Australia

  • Sir Charles Gairdner Hospital

    Perth, Western Australia, Australia

  • St. John of Gog Hospital, Subiaco

    Subiaco, Western Australia, Australia

  • Juravinski Cancer Center

    Hamilton, Ontario, Canada

  • Princess Margaret Hospital

    Toronto, Ontario, Canada

  • McGill University

    Montreal, Quebec, Canada

  • University Hospital Hradec Kralove

    Kralove, Czechia

  • University Hospital Ostrava

    Ostrava- Poruba, Czechia

  • General University Hospital, Department of Obstetrics and Gynecology

    Prague, Czechia

  • Universitaria di Bologna Policlinico

    Bologna, Italy

  • Ospedale di Carpi, AUSL di Modena

    Carpi, Italy

  • Instituto Europeo di Oncologia

    Milan, Italy

  • Oncology IDI- IRCSS

    Roma, Italy

  • III Oddzial Onkologii Ginekologicznej

    Lublin, Poland

  • Oddzial Radioterapii

    Poznan, Poland

  • Klinika Onkologii AM w Poznaniu

    Poznan, Poland

  • Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia de Oncologie Medicala

    Cluj-Napoca, Romania

  • Institutul Oncologic Prof. Dr. Ion. Chiricuta Sectia Radiologie

    Cluj-Napoca, Romania

  • Oncology Medical Centre SCM

    Iași, Romania

  • Clinical Caunty Hospital Mures

    Mures, Romania

  • Central Clinical Hospital

    Moscow, Russia

  • Moscow City Oncology Hospital

    Moscow, Russia

  • State Institution Medical Radiology Scientific Center

    Obninsk, Russia

  • Sity Clinical Oncology

    Saint Petersburg, Russia

  • Ospedale San Giovanni

    Bellinzona, Switzerland

  • Royal Marsden Hospital

    London, United Kingdom

Showing 40 of 46 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.